Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2

References

• ALVARES, A. P. and MANNERING, G. J., 1970, Two substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Molecular Pharmacology, 6, 206–212.
   PubMed Web of Science ®Google Scholar
• CAO, E. H., Liu, X. Q., WANG, J. J. and Xu, N. F., 1996, Effects of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radicals in Biology and Medicine, 20, 801–806.
   PubMed Web of Science ®Google Scholar
• CHEN, C. C., CHEN, H. T., CHEN, Y. P., Hsu, H. Y. and HSIEH, T. C., 1986, Iodation of the components of Salviae miltiorrhizae radix and their coronary dilator activities. Taiwan Yao Hsueh Tsa Chili, 38, 226–230.
   Google Scholar
• DEY, A., JONES, J. E. and NEBERT, D. W., 1999, Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A1 mRNA in the mouse localized in situ hybridization. Biochemical Pharmacology, 58, 525–537.
   PubMed Web of Science ®Google Scholar
• GRADELET, S., ASTROG, P., PINEAU, T., CANIVENC, M. C., SIESS, M. H., LECLREC, J. and LESCA, P., 1997, Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and O.apo-8'-carotenal with no affinity for the TCDD binding site. Biochemical Pharmacology, 54, 307–315.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMER, P., WOLFF, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 26, 5051–5060.
   Google Scholar
• GUENGERICH, F. P., 1994, Analysis and characterization of enzymes. In A. W. Hayes (ed.), Principles and Methods of Toxicology (New York: Plenum), pp. 1259–1313.
   Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 (New York: Plenum), pp. 473–535.
   Google Scholar
• GUENGERICH, F. P., 1997, Role of cytochrome P450 enzymes in drug—drug interactions. Advances in Pharmacology, 43, 7–35.
   PubMedGoogle Scholar
• HONDA, G., KOEZUKA, Y. and TABATA, M., 1988, Isolation of an antidermatophytic substance from the root of Salvia miltiorrhiza. Chemical and Pharmaceutical Bulletin, 36, 408–411.
   PubMed Web of Science ®Google Scholar
• IOANNIDES, C., 2002, Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica, 32, 451–478.
   PubMed Web of Science ®Google Scholar
• KANG, B. Y., CHUNG, S. W., KIM, S. H., RYU, S. Y. and KIM, T. S., 2000, Inhibition of interleukin-12 and interferon--y production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology, 49, 355–361.
   PubMed Web of Science ®Google Scholar
• LIN, J. H. and Lu, A. Y. H., 1998, Inhibition and induction of cytochrome P450 and the clinical implications. Clinical Pharmacokinetics, 35, 361–390.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBOROUGH, N. J., FARR, A. L. and RANDALL, R. L., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416–421.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W. and GELBOIN, H. V., 1968, Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. 1. Assembly and properties of induced enzyme. Journal of Biological Chemistry, 243, 6242–6249.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemeprotein nature. Journal of Biological Chemistry, 239, 2370–2379.
   PubMed Web of Science ®Google Scholar
• ONITSUKA, M., Fujiu, M., SHINMA, N. and MARUYAMA, H. B., 1983, New platelet aggregation inhibitors from Tan-Shen; radix of Salvia miltiorrhiza Bunge. Chemical and Pharmaceutical Bulletin, 31, 1670–1675.
   PubMed Web of Science ®Google Scholar
• PARIKH, A., GILLAM, E. M. J. and GUENGERICH, F. P., 1997, Drug metabolism by Escherichia coli expressing human cytochrome P450. Natural Biotechnology, 15, 784–788.
   Google Scholar
• PETER, R., BOCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-45011E1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, A. H. and LANGDON, R. G., 1962, Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. Journal of Biological Chemistry, 237, 2652–2660.
   PubMed Web of Science ®Google Scholar
• PoilL, R. J. and FOUTS, J. R., 1980, A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Analytical Biochemistry, 107, 150–155.
   PubMed Web of Science ®Google Scholar
• RYU, S. Y., No, Z., KIM, S. H. and AHN, J. W., 1997, Two novel abietane diterpenes from Salvia miltiorrhiza. Planta Medica, 63, 44–46.
   PubMed Web of Science ®Google Scholar
• SATO, M., SATO, T., OSE, Y., NAGASE, H., KITO, H. and SAKAI, Y., 1992, Modulating effect of tanshinones on mutagenic activity of Trp-P-1 and benzo(a)pyrene in Salmonella typhimurium. Mutation Research, 265, 149–154.
   PubMed Web of Science ®Google Scholar
• SCHENKMAN, J. B., REMMER, H. and ESTABROOK, R. W., 1967, Spectral studies of drug interaction with hepatic microsomal cytochrome. Molecular Pharmacology, 3, 113–123.
   PubMed Web of Science ®Google Scholar
• SOUUEK, P., 1999, Cytochrome P450 destruction by quinones: comparison of effects in rat and human liver microsomes. Chemical-Biological Interactions, 121, 223–236.
   PubMed Web of Science ®Google Scholar
• UENG, Y. F., JAN, W. C., LIN, L. C., CHEN, T. L., GUENGERICH, F. P. and CHEN, C. F., 2002, The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metabolism and Disposition, 30, 349–353.
   PubMed Web of Science ®Google Scholar
• Wu, T. W., ZENG, L. H., FUNG, K. P., Wu, J., PANG, H., GREY, A. A., WEISEL, R. D. and WANG, J. Y., 1993, Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochemical Pharmacology, 46, 2327–2332.
   PubMed Web of Science ®Google Scholar
• Wu, W. L., CHANG, W. L. and CHEN, C. F., 1991, Cytotoxic activities of tanshinones against human carcinoma cell lines. American Journal of Chinese Medicine, 19, 207–216.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., INouE, K. and SHIMADA, T., 1998, Roles of two allelic variants (Arg144Cys and ILE359Leu) of cytochrome P450 2C9 in the oxidation of tolbutamide and warfarin by human liver microsomes. Xenobiotica, 28, 103–115.
   PubMed Web of Science ®Google Scholar
• YOON, Y., KIM, Y. O., JEoN, W. K., PARK, H. J. and SUNG, H. J., 1999, Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. Journal of Ethanopharmacology, 58, 121–127.
   Web of Science ®Google Scholar